Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119214695 | 11921469 | 5 | F | 20140610 | 20160804 | 20160115 | 20160811 | PER | US-CELGENEUS-USA-2016011841 | CELGENE | 67.21 | YR | F | Y | 0.00000 | 20160811 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119214695 | 11921469 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | UNKNOWN | 21880 | 25 | MG | CAPSULES | |||||
| 119214695 | 11921469 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | |||||
| 119214695 | 11921469 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | UNKNOWN | 21880 | 15 | MG | CAPSULES | |||||
| 119214695 | 11921469 | 4 | SS | Bortezomib | BORTEZOMIB | 1 | Intramuscular | U | U | UNKNOWN | 0 | 1.3 | MG | UNKNOWN | /wk | ||||
| 119214695 | 11921469 | 5 | SS | Bortezomib | BORTEZOMIB | 1 | Intramuscular | U | U | UNKNOWN | 0 | 1 | MG/M**2 | UNKNOWN | |||||
| 119214695 | 11921469 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | U | UNKNOWN | 0 | 20 | MG | UNKNOWN | |||||
| 119214695 | 11921469 | 7 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | U | U | UNKNOWN | 0 | 8 | MG | UNKNOWN | |||||
| 119214695 | 11921469 | 8 | C | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | 0 | UNKNOWN | /month | |||||||||
| 119214695 | 11921469 | 9 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 119214695 | 11921469 | 10 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 119214695 | 11921469 | 11 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119214695 | 11921469 | 1 | Plasma cell myeloma |
| 119214695 | 11921469 | 4 | Plasma cell myeloma |
| 119214695 | 11921469 | 6 | Plasma cell myeloma |
| 119214695 | 11921469 | 8 | Product used for unknown indication |
| 119214695 | 11921469 | 9 | Product used for unknown indication |
| 119214695 | 11921469 | 10 | Product used for unknown indication |
| 119214695 | 11921469 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119214695 | 11921469 | OT |
| 119214695 | 11921469 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119214695 | 11921469 | Adrenal insufficiency | |
| 119214695 | 11921469 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119214695 | 11921469 | 1 | 20140512 | 20140602 | 0 | |
| 119214695 | 11921469 | 2 | 20140820 | 20141001 | 0 | |
| 119214695 | 11921469 | 3 | 20141022 | 20150415 | 0 | |
| 119214695 | 11921469 | 4 | 20140331 | 20140602 | 0 | |
| 119214695 | 11921469 | 6 | 20140331 | 20140602 | 0 | |
| 119214695 | 11921469 | 8 | 201403 | 0 |